Novo Nordisk Leverages Implant Tech, Oral Pill, and Aggressive Buyback to Counter Eli Lilly’s Moment
The competitive heat from Eli Lilly is forcing Novo Nordisk onto the front foot. The US rival’s tirzepatide…
The best cinnamon bun I’ve ever eaten and more reasons why we travel
I’m Laurie Ochoa, general manager of L.A. Times Food, with a packed summer vacation edition of Tasting Notes.…
Novo Nordisk Bets on CagriSema and Oral Wegovy to Counter Pricing Headwinds and Analysts’ Caution
Novo Nordisk faces key test at ADA with CagriSema Phase 3 data; Wegovy oral prescriptions surge, European reimbursement…
Novo Nordisk’s Buyback Blitz and Oral Wegovy Surge Counter a Bruising Year
Novo Nordisk pushes forward with a DKK 15 billion buyback and oral Wegovy success, while high-dose injectable data…
Novo Nordisk Bets on AI and Subscriptions to Counter a Steep Slide
Novo Nordisk shares surge as the firm partners with OpenAI to accelerate drug development and expands Wegovy subscription…
Novo Nordisk’s Subscription Strategy to Counter Market Pressures
Novo Nordisk counters revenue decline and Eli Lilly’s market lead with a Wegovy subscription model, aiming to lock…
EU seeks minerals club to counter China supply grip
Agencies Ambassadors from the EU’s 27 member states will huddle in Brussels this week to thrash out a…
This Mexican restaurant in Copenhagen is a must-visit spot
Finding great Mexican food in unexpected places. Losing the city of L.A.’s oldest restaurant. A guide to the…